Luke M. Scrivanich, SVP General Manager OSP of VIAVI Solutions Inc. (NASDAQ:VIAV), filed a Form 4 on September 23, 2026, disclosing the vesting of three tranches of market-leveraged stock units and related tax-withholding share disposals on September 22, 2026.
Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (NYSE:HIMS), filed a Form 4 on September 23, 2026, disclosing the exercise of stock options and sale of Class A Common Stock on September 22, 2026, pursuant to a Rule 10b5-1 trading plan.
Ilan Daskal, Executive Vice President and Chief Financial Officer of VIAVI Solutions Inc., filed a Form 4 on September 23, 2026, reporting multiple market stock unit vestings and associated tax-withholding share dispositions that occurred on September 22, 2026.
Oleg Khaykin, President and CEO of Viavi Solutions Inc., filed a Form 4 on September 23, 2026, reporting the vesting of three tranches of market-leveraged stock units on September 22, 2026, along with the company's retention of shares to satisfy related tax withholding obligations.
Paul McNab, Executive Vice President, Chief Marketing and Strategy Officer of VIAVI Solutions Inc., filed a Form 4 on September 23, 2026, reporting the vesting of market-leveraged stock units and related tax withholding disposals that occurred on September 22, 2026.
Anthony Michael Petrucci, Senior Vice President and Chief Operations Officer of VIAVI Solutions Inc. (NASDAQ:VIAV), filed a Form 4 on September 23, 2026, disclosing transactions in common stock and market stock units dated September 22, 2026.
Kevin Christopher Siebert, SVP General Counsel and Secretary of VIAVI Solutions Inc. (NASDAQ:VIAV), filed a Form 4 on September 23, 2026, disclosing the vesting of three tranches of market-leveraged stock units and associated tax-withholding share disposals on September 22, 2026.
Gary W. Staley, SVP Global Sales NSE at VIAVI Solutions Inc. (NASDAQ:VIAV), filed a Form 4 on September 23, 2026, disclosing the vesting and partial tax-withholding disposition of market stock units on September 22, 2026.
Director Peter W. Getsinger filed a Form 4 with the SEC on September 23, 2026, reporting the exercise of a portion of a stock option in Argan Inc (NYSE:AGX) on September 22, 2026.
Luke M. Scrivanich, SVP General Manager OSP at VIAVI Solutions Inc. (NASDAQ:VIAV), filed a Form 4 on September 23, 2026, disclosing the sale of 35,866 shares of common stock pursuant to a pre-established Rule 10b5-1 trading plan.